Joseph E. Gilliam - 08 Dec 2023 Form 4 Insider Report for GLAUKOS Corp (GKOS)

Reporting relationship: PRESIDENT & COO
Issuer ticker: GKOS
Reported as of: 08 Dec 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Dec 2023, 18:59:46 UTC
Prior SEC filing: 18 Sep 2023
Next SEC filing: 22 Dec 2023
Source filing: View source filing
Reporting owner signature: Diana Scherer, Attorney-in-Fact

Key filing fact

Joseph E. Gilliam filed Form 4 for GLAUKOS Corp (GKOS) on 12 Dec 2023.

Key facts

This page summarizes Joseph E. Gilliam's Form 4 filing for GLAUKOS Corp (GKOS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 12 Dec 2023, 18:59.

Change

Previous filing in this sequence was filed on 18 Sep 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GKOS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +3,659
Change %: +9.5%
Price: $0.000000
Shares after: 42,079
Date: 08 Dec 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,659
Exercise price: $55.18
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating & Governance Committee determined on December 8, 2023 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets.

Footnote F2

50% of the portion of the option reported herein will vest and become exercisable in February 2024, and the remaining 50% will vest and become exercisable in November 2024.